CLINICAL_TRIALS research · 2025-06-06

Clinical Trial Update: Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia [Phase 2]

Ongoing Phase 2 clinical trial evaluating treatment efficacy by risk group in relapsed childhood acute lymphoblastic leukemia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Ho Joon Im | Conditions: Acute Lymphoid Leukemia | Phase 2 | Status: RECRUITING